drugset / Trial / NCT02241096

PK Intravenous Lidocaine Infusion

NCT02241096

Phase 1 Terminated 2 enrolled Children's Hospital Medical Center, Cincinnati
NaSingle-groupOpen-labelOther

Summary

To determine safe concentration level of lidocaine infusion in children.

Timeline

Start
2015-01
Primary completion
2015-09
Completion
2015-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.